The Biotech & Life Sciences Conferences Worth Your Attention in 2027

For biotech and life sciences companies, conferences remain an important part of business development, investor engagement, and industry visibility. They create opportunities for conversations that can be difficult to establish through digital channels alone.

But not every conference serves the same purpose, and attending more events does not necessarily produce better results.

As we look toward 2027, companies should be thinking carefully about which conferences support their business priorities, which audiences they need to reach, and how their participation fits within their broader marketing and communications strategy.

Through our work with life sciences companies and industry organizations, including supporting conference communications and executive visibility, we've seen the value of approaching these events with a clear plan.

Here are several conferences across the United States, United Kingdom, and Europe worth considering for 2027.

United States: Investor Access, Partnerships, and Innovation

J.P. Morgan Healthcare Conference | January 11–14 | San Francisco

The annual J.P. Morgan Healthcare Conference remains one of the most significant gatherings for healthcare investors, public companies, industry executives, and emerging organizations.

For companies seeking investment or strategic partnerships, the surrounding conference week offers numerous opportunities for meetings and business development.

Consider it for: Investor relations, financial community engagement, corporate positioning, and business development.

Biotech Showcase | January 11–13 | San Francisco

Co-produced by Demy-Colton and Informa, Biotech Showcase provides a platform for emerging biotechnology companies to connect with investors and biopharmaceutical executives.

Its company presentations, investor discussions, and partnering opportunities make it particularly relevant for organizations preparing for financing, advancing clinical programs, or expanding their industry relationships.

The event also offers specialized programming for early-stage and technology-focused companies.

Consider it for: Emerging biotech companies, investor visibility, company presentations, and strategic partnerships.

TechCon Southwest | January 21 | Dallas

TechCon Southwest brings together founders, investors, technology leaders, and companies working across emerging industries.

Although broader than life sciences, the conference can be particularly relevant for companies operating at the intersection of AI, healthcare technology, digital health, and innovation.

Consider it for: Founder networking, emerging technologies, cross-industry partnerships, and startup visibility.

BIO International Convention | June 7–10 | Philadelphia

BIO International brings together companies, researchers, investors, and organizations from across the global biotechnology industry.

The convention's scale creates opportunities for business development, scientific visibility, and engagement with organizations at different stages of commercialization.

Consider it for: International partnerships, business development, industry networking, and global market visibility.

United Kingdom: Science, Technology, and Industry Relationships

The UK's life sciences ecosystem offers important opportunities for companies looking to build relationships with researchers, investors, technology developers, and business partners.

Festival of Genomics & Biodata | January 27–28 | London

The Festival of Genomics & Biodata brings together professionals working across genomics, precision medicine, data science, and related fields.

For companies developing technologies that connect biology, data, and healthcare, the event provides an opportunity to participate in scientific and industry discussions.

Consider it for: Genomics, precision medicine, AI applications, scientific communications, and research partnerships.

Advanced Therapies UK | March 9–10 | London

Advanced Therapies UK focuses on the development and commercialization of advanced therapies, including cell and gene therapies.

The event connects researchers, biotechnology companies, technology providers, and industry leadership.

Consider it for: Cell and gene therapy companies, emerging therapeutic platforms, scientific visibility, and industry partnerships.

Jefferies Global Healthcare Conference | 2027 Dates Forthcoming | London

The Jefferies Global Healthcare Conference is an important event for public and private healthcare companies and institutional investors.

Its focus on investment opportunities and industry developments makes it worth monitoring for biotechnology companies with established investor relations priorities.

Consider it for: Institutional investor engagement, public-market visibility, and corporate development.

Europe: Expanding Global Partnerships

BIO-Europe Spring | April 5–7 | Lyon, France

BIO-Europe Spring brings together biotechnology companies, pharmaceutical organizations, investors, and research institutions for international partnering.

For companies expanding their relationships beyond domestic markets, the event offers a focused environment for licensing discussions, business development, and potential partnerships.

Consider it for: International business development, licensing, and pharmaceutical partnerships.

LSX Investival Europe | April 7–8 | Lyon, France

Taking place during the same industry week as BIO-Europe Spring, LSX Investival Europe focuses on life sciences investment and fundraising.

Its emphasis on connecting companies with investors makes it particularly relevant for early-stage biotechnology companies and university spinouts.

Consider it for: Fundraising, investor introductions, and early-stage company visibility.

BIO-Europe | Autumn 2027 | Details Forthcoming

The autumn BIO-Europe conference is another important opportunity for international business development and industry networking.

Companies considering European expansion or new commercial relationships should keep it on their planning calendars as event details become available.

Choosing Conferences Based on Business Priorities

The right conference strategy starts with understanding what the company needs to accomplish.

A clinical-stage biotech preparing for a financing round may prioritize investor meetings and company presentations. A growing technology company may benefit more from events focused on partnerships, industry recognition, or commercial opportunities.

A company entering a new geographic market may need a different approach altogether.

Before committing to a conference, leadership teams should consider:

• Which investors, partners, or industry stakeholders will attend?
• What business milestones can the company discuss?
• Are there opportunities for executive speaking engagements or company presentations?
• What existing relationships can be developed further?
• How will success be evaluated after the event?

The answers should influence everything from event selection to the communications plan.

Your Conference Strategy Should Begin Before Registration

Conference participation is most valuable when it connects to the company's broader business objectives.

Marketing and communications should support business development well before the event begins. This includes executive visibility, targeted outreach, appropriate company updates, and a clear digital presence.

During the conference, companies should focus on meaningful engagement rather than simply producing a high volume of content.

Afterward, timely follow-up and continued communication can help turn initial introductions into lasting professional relationships.

Looking Ahead

The 2027 conference calendar presents opportunities across the US, UK, and Europe for biotechnology and life sciences companies at different stages of development.

The most valuable events aren't necessarily the largest or most widely attended. They're the ones that bring companies closer to the people, conversations, and relationships that support their business.

At Mauve Social, we work with companies and industry organizations on strategic marketing, executive visibility, and communications around important milestones and industry events.

As organizations begin planning for 2027, the priority should be choosing conferences with purpose and developing a strategy that extends well beyond the event itself.

‍